Pulmonx Corporation (LUNG) Tops Q3 EPS by 8c

Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $21.5 million versus the consensus estimate of $20.78 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• SK Hynix (SKHY) call put ratio 1.2 calls to 1 put as share price up 4.7%
• Stifel on COMPASS Pathways plc (CMPS): 'COMP360 continues to be well-tolerated'